CSPC Pharmaceutical : POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2017

CSPC Pharmaceutical Group Limited (the "Company") is pleased to announce the poll results in respect of the resolutions proposed at the annual general meeting (the "AGM") of the Company held on 25 May 2017 as follows:

ORDINARY RESOLUTIONS		Number of Votes (%)
		For	Against
1.	To receive and consider the audited financial statements, the report of the directors and the independent auditor's report for the year ended 31 December 2016	4,124,473,169 (99.98%)	628,000 (0.02%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
2.	To declare a final dividend of HK12 cents per share for the year ended 31 December 2016	4,125,601,169 (100.00%)	0 (0.00%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
3.	(a)(i) To re-elect Mr. CAI Dongchen, as an executive director	3,499,540,568 (85.17%)	609,564,601 (14.83%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
	(a)(ii) To re-elect Mr. CHAK Kin Man as an executive director	3,974,132,877 (96.35%)	150,694,292 (3.65%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
	(a)(iii) To re-elect Mr. PAN Weidong as an executive director	3,974,458,877 (96.35%)	150,368,292 (3.65%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed

ORDINARY RESOLUTIONS		Number of Votes (%)
		For	Against
(a)(iv) To re-elect Mr. LEE Ka Sze, Carmelo as a non-executive director	3,046,605,478 (74.59%)	1,037,972,133 (25.41%)
As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
(a)(v) To re-elect Mr. CHEN Chuan as an independent non-executive director	4,107,261,827 (99.56%)	18,339,342 (0.44%)
As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
(b) To authorise the board of directors to fix the remuneration of directors	3,940,168,215 (97.98%)	81,272,004 (2.02%)
As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
4.	To re-appoint Messrs. Deloitte Touche Tohmatsu as auditor and to authorise the board of directors to fix the remuneration of auditor	4,111,427,169 (99.66%)	14,150,000 (0.34%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed
5.	To give a general mandate to the Directors to buy-back shares of the Company (ordinary resolution in item No.5 of the Notice of Annual General Meeting)	4,117,281,169 (99.84%)	6,538,000 (0.16%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed as an ordinary resolution
6.	To give a general mandate to the Directors to issue new shares of the Company (ordinary resolution in item No.6 of the Notice of Annual General Meeting)	2,406,752,993 (58.36%)	1,717,370,176 (41.64%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed as an ordinary resolution
7.	To extend the general mandate to be given to the Directors to issue shares (ordinary resolution in item No.7 of the Notice of Annual General Meeting)	2,559,858,978 (62.07%)	1,564,264,191 (37.93%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed as an ordinary resolution
8.	To grant a mandate to the Directors to grant options under the Share Option Scheme of the Company (ordinary resolution in item No.8 of the Notice of Annual General Meeting)	3,111,165,696 (75.42%)	1,013,879,473 (24.58%)
	As more than 50% of the votes were cast in favour of this ordinary resolution, the resolution was duly passed as an ordinary resolution
SPECIAL RESOLUTION		Number of Votes (%)
		For	Against
9.	To adopt the new articles of association of the Company (special resolution in item No.9 of the Notice of Annual General Meeting )	4,107,849,019 (99.57%)	17,752,150 (0.43%)
	As more than 75% of the votes were cast in favour of this special resolution, the resolution was duly passed as a special resolution.

As at the date of the AGM, the total number of issued and fully paid up shares of the Company was 6,054,018,403 shares. In relation to all resolutions proposed at the AGM, the total number of shares entitling the holders to attend and vote for or against the resolutions at the AGM was 6,054,018,403 shares. There were no shares entitling the holders to attend and abstain from voting in favour of the resolutions at the AGM as set out in Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and no holder of shares was required to abstain from voting at the AGM under the Listing Rules.

Tricor Secretaries Limited, the Share Registrar of the Company, acted as scrutineer for the poll at the AGM.

Shareholders may refer to the circular dated 20 April 2017 for details of the above resolutions proposed at the AGM. The circular may be viewed and downloaded from the Company's website at www.irasia.com/listco/hk/cspcor the designated website of The Hong Kong Exchanges and Clearing Limited atwww.hkexnews.hk.

By order of the board

CSPC Pharmaceutical Group Limited

CAI Dongchen

Chairman

Hong Kong, 25 May 2017

As at the date of this notice, the Board comprises Mr. CAI Dongchen, Mr. PAN Weidong, Mr. WANG Huaiyu, Mr. LU Jianmin, Mr. WANG Jinxu, Mr. WANG Zhenguo, Mr. LU Hua and Mr. CHAK Kin Man as executive Directors; Mr. LEE Ka Sze, Carmelo as non-executive Director and Mr. CHAN Siu Keung, Leonard, Mr. WANG Bo, Mr. LO Yuk Lam, Mr. YU Jinming and Mr. CHEN Chuan as independent non-executive Directors.